Aging-related diseases, including cancer, cardiovascular disorders and type 2 diabetes, are associated with defects in ...

Aging-related diseases, including cancer, cardiovascular disorders and type 2 diabetes, are associated with defects in ...

Aging-related diseases, including cancer, cardiovascular disorders and type 2 diabetes, are associated with defects in protein synthesis and ...

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...

David Baker’s lab has successfully designed binders to disordered proteins, expanding therapeutic access to over 50% of the ...

Visteon Corporation (NASDAQ: VC), a global leader in automotive cockpit electronics and connected car solutions, today ...

With no revenue expected, VKTX's Q2 report is likely to have the spotlight on pipeline moves across its obesity drugs.

Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...